Merit Medical Systems, Inc. (MM3.F)

73,00 +2,50 (+3,55%) Börsenschluss: 09:49PM CEST

Merit Medical Systems, Inc.

1600 West Merit Parkway
South Jordan, UT 84095
United States
801 253 1600
https://www.merit.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 6.950

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Fred P. Lampropoulos	Founder, Chairman, CEO & President	3M	7,24M	1950
Mr. Raul Parra Jr., CPA	CFO & Treasurer	993,44k	179,85k	1978
Mr. Neil W. Peterson	Chief Operating Officer	936,2k	596,07k	1967
Mr. Brian G. Lloyd	Chief Legal Officer & Corporate Secretary	889,89k	N/A	1961
Mr. Joseph C. Wright	Chief Commercial Officer	1,03M	N/A	1970
Mr. Jason Treft	Chief Information Officer	N/A	N/A	N/A
Sarah Comstock	Vice President of Global Communications	N/A	N/A	N/A
JoAnne Alkire	Executive Vice President of Global Marketing & Strategy	N/A	N/A	N/A
Mr. Michel J. Voigt	Chief Human Resources Officer	N/A	N/A	1973
Mr. John Knorpp	Chief Regulatory Affairs Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Corporate Governance

Merit Medical Systems, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 2. Die grundlegenden Scores sind Audit: 1, Vorstand: 5, Shareholderrechte: 3, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.